Philipp Markart

5.6k total citations
85 papers, 4.0k citations indexed

About

Philipp Markart is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Physiology. According to data from OpenAlex, Philipp Markart has authored 85 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 14 papers in Hematology and 12 papers in Physiology. Recurrent topics in Philipp Markart's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Neonatal Respiratory Health Research (19 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Philipp Markart is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (42 papers), Neonatal Respiratory Health Research (19 papers) and Blood Coagulation and Thrombosis Mechanisms (13 papers). Philipp Markart collaborates with scholars based in Germany, Austria and United States. Philipp Markart's co-authors include Clemens Ruppert, Werner Seeger, Małgorzata Wygrecka, Andreas Güenther, Andreas Günther, Klaus T. Preissner, Ingrid Henneke, Friedrich Grimminger, Martina Korfei and Poornima Mahavadi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Philipp Markart

78 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Philipp Markart 2.0k 841 590 524 516 85 4.0k
Mitsuhiro Takeno 1.0k 0.5× 1.2k 1.4× 718 1.2× 505 1.0× 598 1.2× 144 4.8k
Małgorzata Wygrecka 1.9k 0.9× 1.6k 1.9× 970 1.6× 461 0.9× 370 0.7× 127 4.9k
A Dewar 1.8k 0.9× 1.4k 1.6× 727 1.2× 620 1.2× 194 0.4× 89 4.5k
Bernadette R. Gochuico 2.5k 1.2× 977 1.2× 797 1.4× 576 1.1× 173 0.3× 100 4.7k
Raphael Breuer 1.9k 0.9× 564 0.7× 360 0.6× 378 0.7× 145 0.3× 113 3.1k
Hidenori Nakamura 1.9k 1.0× 664 0.8× 499 0.8× 464 0.9× 92 0.2× 166 3.8k
S. I. Rennard 1.5k 0.7× 624 0.7× 427 0.7× 453 0.9× 165 0.3× 37 3.5k
Steven Idell 3.2k 1.6× 1.4k 1.7× 796 1.3× 1.0k 2.0× 926 1.8× 226 6.3k
Benjamin T. Suratt 1.2k 0.6× 710 0.8× 1.1k 1.9× 477 0.9× 99 0.2× 68 3.4k
Ling‐Pei Ho 1.1k 0.5× 675 0.8× 1.1k 1.8× 573 1.1× 208 0.4× 74 3.5k

Countries citing papers authored by Philipp Markart

Since Specialization
Citations

This map shows the geographic impact of Philipp Markart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Markart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Markart more than expected).

Fields of papers citing papers by Philipp Markart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Markart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Markart. The network helps show where Philipp Markart may publish in the future.

Co-authorship network of co-authors of Philipp Markart

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Markart. A scholar is included among the top collaborators of Philipp Markart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Markart. Philipp Markart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drakopanagiotakis, Fotios, Philipp Markart, & Paschalis Steiropoulos. (2023). Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers. International Journal of Molecular Sciences. 24(12). 10196–10196. 13 indexed citations
2.
Kreuter, Michael, Jürgen Behr, Francesco Bonella, et al.. (2023). S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter. Pneumologie. 77(5). 269–302. 19 indexed citations
3.
Zakrzewicz, Dariusz, Anna Zakrzewicz, Miroslava Didiášová, et al.. (2015). Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(12). 2678–2688. 21 indexed citations
4.
Ruppert, Clemens, et al.. (2014). Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis. European Respiratory Journal. 44(Suppl 58). P772–P772. 1 indexed citations
5.
Drakopanagiotakis, Fotios, Silke Tello, Daniel von der Beck, et al.. (2014). Intraindividual response to treatment with pirfenidone in two independent European IPF cohorts. European Respiratory Journal. 44(Suppl 58). P762–P762. 1 indexed citations
6.
Kwapiszewska, Grażyna, Philipp Markart, Bhola K. Dahal, et al.. (2012). PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension. Circulation Research. 110(9). 1179–1191. 50 indexed citations
7.
Wygrecka, Małgorzata, Dariusz Zakrzewicz, Brigitte Taborski, et al.. (2012). TGF-β1 Induces Tissue Factor Expression in Human Lung Fibroblasts in a PI3K/JNK/Akt-Dependent and AP-1–Dependent Manner. American Journal of Respiratory Cell and Molecular Biology. 47(5). 614–627. 46 indexed citations
8.
Grommes, Jochen, Jean-Éric Alard, Maik Drechsler, et al.. (2012). Disruption of Platelet-derived Chemokine Heteromers Prevents Neutrophil Extravasation in Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 185(6). 628–636. 183 indexed citations
9.
Wygrecka, Małgorzata, Grażyna Kwapiszewska, Ewa Jabłońska, et al.. (2011). Role of Protease-activated Receptor-2 in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 183(12). 1703–1714. 76 indexed citations
10.
Wygrecka, Małgorzata, Jochen Wilhelm, Ewa Jabłońska, et al.. (2011). Shedding of Low-Density Lipoprotein Receptor–related Protein-1 in Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 184(4). 438–448. 39 indexed citations
11.
Markart, Philipp, Małgorzata Wygrecka, & Andreas Güenther. (2011). Update in Diffuse Parenchymal Lung Disease 2010. American Journal of Respiratory and Critical Care Medicine. 183(10). 1316–1321. 2 indexed citations
12.
Markart, Philipp, Robert D. Nass, Clemens Ruppert, et al.. (2010). Safety and Tolerability of Inhaled Heparin in Idiopathic Pulmonary Fibrosis. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(3). 161–172. 43 indexed citations
13.
Henneke, Ingrid, Susanne Greschus, Rajkumar Savai, et al.. (2010). Inhibition of Urokinase Activity Reduces Primary Tumor Growth and Metastasis Formation in a Murine Lung Carcinoma Model. American Journal of Respiratory and Critical Care Medicine. 181(6). 611–619. 42 indexed citations
14.
Mahavadi, Poornima, Martina Korfei, Ingrid Henneke, et al.. (2010). Epithelial Stress and Apoptosis Underlie Hermansky-Pudlak Syndrome–associated Interstitial Pneumonia. American Journal of Respiratory and Critical Care Medicine. 182(2). 207–219. 71 indexed citations
15.
Ruppert, Clemens, Sebastian Schmidt, Ingrid Henneke, et al.. (2010). Dry powder aerosolization of a recombinant surfactant protein-C–based surfactant for inhalative treatment of the acutely inflamed lung*. Critical Care Medicine. 38(7). 1584–1591. 26 indexed citations
16.
Korfei, Martina, Clemens Ruppert, Poornima Mahavadi, et al.. (2008). Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 178(8). 838–846. 388 indexed citations
17.
Jabłońska, Ewa, Andreas Güenther, Klaus Preissner, Philipp Markart, & Małgorzata Wygrecka. (2008). Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases. Thrombosis and Haemostasis. 99(3). 494–501. 73 indexed citations
18.
Günther, Andreas, Monika Ermert, Ralph T. Schermuly, et al.. (2003). Prevention of Bleomycin-induced Lung Fibrosis by Aerosolization of Heparin or Urokinase in Rabbits. American Journal of Respiratory and Critical Care Medicine. 168(11). 1358–1365. 137 indexed citations
19.
Markart, Philipp, Thomas R. Korfhagen, Timothy E. Weaver, & Henry T. Akinbi. (2003). Mouse Lysozyme M Is Important in Pulmonary Host Defense against Klebsiella pneumoniae Infection. American Journal of Respiratory and Critical Care Medicine. 169(4). 454–458. 67 indexed citations
20.
Günther, Andreas, S Heinemann, Clemens Ruppert, et al.. (2000). Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia: Comparison with the Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 161(2). 454–462. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsuhiro Takeno Breakdown of academic impact, for papers by Małgorzata Wygrecka Breakdown of academic impact, for papers by A Dewar Breakdown of academic impact, for papers by Bernadette R. Gochuico Breakdown of academic impact, for papers by Raphael Breuer Breakdown of academic impact, for papers by Hidenori Nakamura Breakdown of academic impact, for papers by S. I. Rennard Breakdown of academic impact, for papers by Steven Idell Breakdown of academic impact, for papers by Benjamin T. Suratt Breakdown of academic impact, for papers by Ling‐Pei Ho
Rankless by CCL
2026